top of page

Drug Successfully Delays Common Form of Breast Cancer

Dec 5 (Reuters)—An experimental drug showed impressive effectiveness and safety in a mid-stage trial against a common form of advanced breast cancer, lifting Pfizer Inc shares nearly 2 percent.

The favorable results prompted the drugmaker to plan large late-stage trials of the drug next year. If approved, the medicine could fetch multi-billion dollar sales, industry analysts said.

Comentários


NEWSLETTERS

Get Reason In Your Inbox.

Thanks for submitting!

Join the

LIBERTARIAN PARTY

We are funded entirely by Americans who want to help give liberty a voice. By joining the Libertarian Party as a dues-paying member, you are investing in this critical work.

Thanks for submitting!

ADDRESS

1444 Duke St.

Alexandria, VA 22314-3403

PHONE

(800) ELECT-US

(800) 353-2887

EMAIL

bottom of page